insider brief
- The BioInnovation Institute (BII) announced that 12 new companies have joined its Venture Lab acceleration program for early-stage companies.
- Of the 12 companies, 2 are quantum companies. Alea Quantum Technologies and dia senseis participating in the Venture Lab program for the first time in BII's history.
- Both companies will receive financial support of EUR 500,000, as well as access to infrastructure, business development expertise and an extensive investor network.
- Image: News Ålesund/Wikimedia
PRESS RELEASE — The BioInnovation Institute (BII), an international nonprofit foundation that fosters and accelerates world-class life sciences research, today announced 12 new companies have joined its Venture Lab Acceleration Program for early-stage companies. did.
As part of BII’s internal quantum startup accelerator, Deep Tech Lab – Quantum, in collaboration with two quantum companies; Alea Quantum Technologiesand dia senseis participating in the Venture Lab program for the first time in BII's history. Through the Venture Lab program, both companies will receive his €500,000 financial support, infrastructure, business development expertise and access to an extensive investor network to commercialize their technology, which has great potential in the life sciences market. get closer to.
“We are excited to accelerate and leverage the potential synergies between life sciences and quantum technologies that we have already identified, particularly in quantum computing and sensing. The two quantum companies we have chosen to support are great examples of how quantum technology can enable better products and solutions for the life sciences industry,” said Cathal, Chief Business Officer, Deep Tech Lab – Quantum. Mahon said.
The two quantum companies represent solutions that will have a major impact on the life sciences industry.
Alea Quantum Technologies is becoming increasingly important to the need to protect digitized patients as genomic data becomes the basis for diagnostic development and optimization. The company has developed an extremely fast quantum random number generator that has the potential to provide a compact and cost-effective solution for rapidly encrypting large amounts of patient data.
DiaSense is a spin-out company from the Technical University of Denmark that develops a new type of quantum microscope. Microscopy is the driving force behind numerous scientific discoveries and medical technology developments, so it may have great commercial potential in the life sciences industry.
Promoting cross-collaboration
Building on BII's unique platform, these newly founded quantum companies will collaborate with companies contributing to solutions in the areas of therapeutics, women's health, planetary health, and health technology.
Bobby Soni, chief business officer at the BioInnovation Institute, sees great potential in collaborating across industries and scientific boundaries.
“These 12 startups, operating across the planetary, therapeutics, women’s health, health technology, and quantum industries, align with BII’s mission to create innovative solutions that address current challenges in these areas. They have demonstrated drive and tenacity. We are proud to help these startups innovate by providing the knowledge, networks, capital, and infrastructure to build successful companies. I’m looking forward to it,” he says.
Since its founding in 2018, BII has backed 100 startups and projects with €89 million, providing venture capital, industry and business expertise to help them accelerate to the next level.
BII startups have raised over €428 million in external funding from national and international investors. Recent company successes include Embark Laboratories, Adcendo, Stipe Therapeutics, Twelve Bio, Octarine Bio, and Cirqle Biomedical.
Deep Tech Lab — Quantum is an independent organization founded in 2023 by the BioInnovation Institute to support Denmark's world-leading quantum physics research and the creation, development, and development of start-ups and spin-outs in the life sciences sector. It aims to leverage BII's superior recognition in maturation. Deep Tech Lab – Quantum is currently collaborating with other quantum startups as part of NATO's DIANA program.
Detailed information on the BioInnovation Institute
Deep Tech Lab – Learn more about Quantum
